On the heterogeneity of depression in Parkinson’s disease
Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which reduces quality of life in patients.Objective: to compare the clinical features of depression at different stages of PD.Patients and methods. Examinations were made in 162 PD patients aged 62.14±1.99 ye...
Saved in:
| Main Authors: | M. R. Nodel, N. N. Yakhno |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2020-10-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1446 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®)
by: M. R. Nodel
Published: (2011-09-01) -
Pathogenesis, clinical features, and treatments of depression in Parkinson's disease
by: I. V. Milyukhina
Published: (2019-06-01) -
Early-onset Parkinson's disease and depression Doença de Parkinson de início precoce e depressão
by: Délcio Bertucci Filho, et al.
Published: (2007-03-01) -
Characterizing microglial heterogeneity in autophagy impairment of Paraquat-induced Parkinson’s disease-like neurodegeneration
by: Yu Zhang, et al.
Published: (2025-07-01) -
Efficacy and safety of Wuling capsule for the treatment of mild depression in patients with early Parkinson’s disease in China: a randomized clinical trial
by: Yuwen Zhao, et al.
Published: (2025-07-01)